• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Comprehensive Overview of N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride (CAS No. 1185294-98-7)

N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride (CAS No. 1185294-98-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, often referred to by its abbreviated name, features a unique molecular structure combining a pyrazole ring and a phenylmethanamine backbone, making it a subject of interest for drug discovery and development. Researchers are particularly intrigued by its potential applications in modulating neurotransmitter systems, which aligns with current trends in neuroscience and mental health therapeutics.

The compound's CAS number 1185294-98-7 serves as a critical identifier in chemical databases, ensuring precise tracking in regulatory and research contexts. Its dihydrochloride salt form enhances solubility and stability, which are essential properties for in vitro and in vivo studies. Given the rising demand for novel psychoactive compounds in treating conditions like depression and anxiety, N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride is frequently discussed in forums and publications focusing on central nervous system (CNS) drug development.

One of the most searched questions related to this compound is: "What are the potential therapeutic uses of N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride?" Preliminary studies suggest its interaction with serotonin and dopamine receptors, which could explain its relevance in mood disorder research. Additionally, its pyrazole moiety is a common pharmacophore in medicinal chemistry, often associated with anti-inflammatory and anticancer properties, further broadening its investigational scope.

From a synthetic chemistry perspective, the preparation of CAS 1185294-98-7 involves multi-step organic reactions, including N-methylation and pyrazole ring formation. These processes are frequently optimized to improve yield and purity, addressing another common query: "How is N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride synthesized?" Advanced techniques like HPLC and NMR spectroscopy are employed to characterize the compound, ensuring compliance with industry standards.

In the context of SEO optimization, this article targets high-traffic keywords such as "pyrazole derivatives in drug discovery" and "CAS 1185294-98-7 applications", which are frequently searched by academic and industrial researchers. The compound's potential role in neuropharmacology and medicinal chemistry aligns with trending topics like personalized medicine and targeted therapy, enhancing its visibility in scientific literature and online databases.

Another area of interest is the compound's structure-activity relationship (SAR), a hot topic in computational chemistry. Researchers often explore how modifications to the phenylmethanamine or pyrazole groups affect biological activity. This aligns with the growing use of AI-driven drug design, where predictive modeling accelerates the identification of promising candidates like N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride.

Regulatory and safety profiles of CAS 1185294-98-7 are also frequently queried. While the compound is not classified as hazardous, proper handling protocols are emphasized in laboratory safety guidelines. Its dihydrochloride form ensures safer storage and handling compared to freebase analogs, addressing concerns about chemical stability and workplace safety.

In summary, N-Methyl-1-3-(1H-pyrazol-1-yl)phenylmethanamine Dihydrochloride (CAS No. 1185294-98-7) represents a versatile scaffold in modern drug development. Its intersection with CNS research, medicinal chemistry, and computational modeling makes it a compelling subject for ongoing and future studies. By addressing frequently asked questions and leveraging SEO-friendly keywords, this overview aims to provide a valuable resource for researchers and industry professionals alike.

• 368870-03-5((4-(1H-Pyrazol-1-yl)phenyl)methanamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)